Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Sep;2(5):549–553. doi: 10.1128/cdli.2.5.549-553.1995

Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin.

P Villa 1, G Sartor 1, M Angelini 1, M Sironi 1, M Conni 1, P Gnocchi 1, A M Isetta 1, G Grau 1, W Buurman 1, L J van Tits 1, et al.
PMCID: PMC170198  PMID: 8548533

Abstract

The production of tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and IL-6 and their pharmacomodulation were evaluated in a model of polymicrobial sepsis induced in mice by cecal ligation and puncture (CLP) and were compared with the effects of endotoxin (lipopolysaccharide [LPS]) treatment. LPS levels rose as early as 1 h after CLP and increased further after 2 and 21 h. TNF-alpha was detectable in serum, spleen, liver, and lungs during the first 4 h, with a peak 2 h after CLP. IL-1 beta was measurable in serum after 24 h, and levels increased significantly in spleen and liver 4 and 8 h after CLP. IL-6 levels increased significantly in serum throughout the first 16 h after CLP. These cytokines were detectable after LPS injection, with kinetics similar to those after CLP but at a significantly higher level. To cast more light on the differences between these two animal models of septic shock, we studied the effects of different reference drugs. Pretreatment with dexamethasone (DEX); ibuprofen (IBU), an inhibitor of cyclooxygenase; and NG-nitro-L-arginine, an inhibitor of nitric oxide synthase, significantly reduced survival, while chlorpromazine (CPZ) and TNF did not affect it. Only the antibiotics and pentoxifylline significantly increased survival in mice with CLP. However, CPZ and DEX protected the mice from LPS mortality. On inhibiting TNF-alpha with DEX, CPZ, or pentoxifylline, survival was reduced, unchanged, and increased, respectively, and on increasing TNF-alpha with IBU and TNF, survival was decreased or unchanged, respectively, suggesting that the modulation of this cytokine does not play a significant role in sepsis induced by CLP, unlike treatment with LPS. The negative effects of IBU and N(G)-nitro-L-arginine suggest a protective role by prostaglandins and nitric oxide in sepsis induced by CLP.

Full Text

The Full Text of this article is available as a PDF (235.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander H. R., Doherty G. M., Venzon D. J., Merino M. J., Fraker D. L., Norton J. A. Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats. Surgery. 1992 Aug;112(2):188–194. [PubMed] [Google Scholar]
  2. Alexander H. R., Sheppard B. C., Jensen J. C., Langstein H. N., Buresh C. M., Venzon D., Walker E. C., Fraker D. L., Stovroff M. C., Norton J. A. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. J Clin Invest. 1991 Jul;88(1):34–39. doi: 10.1172/JCI115298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baker C. C., Chaudry I. H., Gaines H. O., Baue A. E. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983 Aug;94(2):331–335. [PubMed] [Google Scholar]
  4. Bemelmans M. H., Gouma D. J., Buurman W. A. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma. J Immunol. 1993 Nov 15;151(10):5554–5562. [PubMed] [Google Scholar]
  5. Bertini R., Bianchi M., Mengozzi M., Ghezzi P. Protective effect of chlorpromazine against the lethality of interleukin 1 in adrenalectomized or actinomycin D-sensitized mice. Biochem Biophys Res Commun. 1989 Dec 29;165(3):942–946. doi: 10.1016/0006-291x(89)92694-6. [DOI] [PubMed] [Google Scholar]
  6. Bertini R., Delgado R., Faggioni R., Gascon M. P., Ythier A., Ghezzi P. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock. Eur Cytokine Netw. 1993 Jan-Feb;4(1):39–42. [PubMed] [Google Scholar]
  7. Beutler B., Milsark I. W., Cerami A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985 Aug 30;229(4716):869–871. doi: 10.1126/science.3895437. [DOI] [PubMed] [Google Scholar]
  8. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987 Sep 10;317(11):653–658. doi: 10.1056/NEJM198709103171101. [DOI] [PubMed] [Google Scholar]
  9. Chalkiadakis G. E., Kostakis A., Karayannacos P. E., Chalkiadakis M. E., Sgouromali S., Giamarellou H., Skalkeas G. D. Pentoxifylline in the treatment of experimental peritonitis in rats. Arch Surg. 1985 Oct;120(10):1141–1144. doi: 10.1001/archsurg.1985.01390340039007. [DOI] [PubMed] [Google Scholar]
  10. Cobb J. P., Natanson C., Hoffman W. D., Lodato R. F., Banks S., Koev C. A., Solomon M. A., Elin R. J., Hosseini J. M., Danner R. L. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med. 1992 Oct 1;176(4):1175–1182. doi: 10.1084/jem.176.4.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. De Groote D., Grau G. E., Dehart I., Franchimont P. Stabilisation of functional tumor necrosis factor-alpha by its soluble TNF receptors. Eur Cytokine Netw. 1993 Sep-Oct;4(5):359–362. [PubMed] [Google Scholar]
  12. Echtenacher B., Falk W., Männel D. N., Krammer P. H. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol. 1990 Dec 1;145(11):3762–3766. [PubMed] [Google Scholar]
  13. Eskandari M. K., Bolgos G., Miller C., Nguyen D. T., DeForge L. E., Remick D. G. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol. 1992 May 1;148(9):2724–2730. [PubMed] [Google Scholar]
  14. Evans G. F., Snyder Y. M., Butler L. D., Zuckerman S. H. Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. Circ Shock. 1989 Dec;29(4):279–290. [PubMed] [Google Scholar]
  15. Gadina M., Bertini R., Mengozzi M., Zandalasini M., Mantovani A., Ghezzi P. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med. 1991 Jun 1;173(6):1305–1310. doi: 10.1084/jem.173.6.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gianotti L., Alexander J. W., Pyles T., Fukushima R. Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide. Ann Surg. 1993 Jun;217(6):644–654. doi: 10.1097/00000658-199306000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gianotti L., Alexander J. W., Pyles T., Fukushima R., Babcock G. F. Prostaglandin E1 analogues misoprostol and enisoprost decrease microbial translocation and modulate the immune response. Circ Shock. 1993 Aug;40(4):243–249. [PubMed] [Google Scholar]
  18. Gnocchi P., Losa C., Trizio D., Isetta A. M. Development and applications of a radioimmunoassay (RIA) for the in vitro and in vivo quantification of murine IL-1 beta. Lymphokine Cytokine Res. 1992 Oct;11(5):257–263. [PubMed] [Google Scholar]
  19. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982 Oct;126(1):131–138. doi: 10.1016/0003-2697(82)90118-x. [DOI] [PubMed] [Google Scholar]
  20. Hofsli E., Bakke O., Nonstad U., Espevik T. A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes. Cell Immunol. 1989 Sep;122(2):405–415. doi: 10.1016/0008-8749(89)90087-7. [DOI] [PubMed] [Google Scholar]
  21. Jardin F., Valtier B., Beauchet A., Dubourg O., Bourdarias J. P. Invasive monitoring combined with two-dimensional echocardiographic study in septic shock. Intensive Care Med. 1994 Nov;20(8):550–554. doi: 10.1007/BF01705720. [DOI] [PubMed] [Google Scholar]
  22. Josaki K., Contrino J., Kristie J., Krause P., Kreutzer D. L. Pentoxifylline-induced modulation of human leukocyte function in vitro. Am J Pathol. 1990 Mar;136(3):623–630. [PMC free article] [PubMed] [Google Scholar]
  23. Kubes P., Suzuki M., Granger D. N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4651–4655. doi: 10.1073/pnas.88.11.4651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lantz M., Gullberg U., Nilsson E., Olsson I. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J Clin Invest. 1990 Nov;86(5):1396–1402. doi: 10.1172/JCI114853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lechner A. J., Rouben L. R., Potthoff L. H., Tredway T. L., Matuschak G. M. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Circ Shock. 1993 Apr;39(4):306–315. [PubMed] [Google Scholar]
  26. Matuschak G. M., Klein C. A., Tredway T. L., Schilly D. R., Lechner A. J. TNF-alpha and cyclooxygenase metabolites do not modulate C. albicans septic shock with disseminated candidiasis. J Appl Physiol (1985) 1993 May;74(5):2432–2442. doi: 10.1152/jappl.1993.74.5.2432. [DOI] [PubMed] [Google Scholar]
  27. Mengozzi M., Fantuzzi G., Faggioni R., Marchant A., Goldman M., Orencole S., Clark B. D., Sironi M., Benigni F., Ghezzi P. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology. 1994 Jun;82(2):207–210. [PMC free article] [PubMed] [Google Scholar]
  28. Munoz C., Misset B., Fitting C., Blériot J. P., Carlet J., Cavaillon J. M. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol. 1991 Sep;21(9):2177–2184. doi: 10.1002/eji.1830210928. [DOI] [PubMed] [Google Scholar]
  29. Noel P., Nelson S., Bokulic R., Bagby G., Lippton H., Lipscomb G., Summer W. Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci. 1990;47(12):1023–1029. doi: 10.1016/0024-3205(90)90474-6. [DOI] [PubMed] [Google Scholar]
  30. Oka Y., Murata A., Nishijima J., Hiraoka N., Yasuda T., Kitagawa K., Ogawa M., Mori T. Inhibitory effect of pentoxifylline and prostaglandin E1 on the release of neutrophil elastase from FMLP-stimulated neutrophils. J Med. 1991;22(6):371–382. [PubMed] [Google Scholar]
  31. Schleiffenbaum B., Fehr J. The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation. J Clin Invest. 1990 Jul;86(1):184–195. doi: 10.1172/JCI114683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sironi M., Gadina M., Kankova M., Riganti F., Mantovani A., Zandalasini M., Ghezzi P. Differential sensitivity of in vivo TNF and IL-6 production to modulation by anti-inflammatory drugs in mice. Int J Immunopharmacol. 1992 Aug;14(6):1045–1050. doi: 10.1016/0192-0561(92)90149-f. [DOI] [PubMed] [Google Scholar]
  33. Sáez-Llorens X., McCracken G. H., Jr Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. J Pediatr. 1993 Oct;123(4):497–508. doi: 10.1016/s0022-3476(05)80942-4. [DOI] [PubMed] [Google Scholar]
  34. Wichterman K. A., Baue A. E., Chaudry I. H. Sepsis and septic shock--a review of laboratory models and a proposal. J Surg Res. 1980 Aug;29(2):189–201. doi: 10.1016/0022-4804(80)90037-2. [DOI] [PubMed] [Google Scholar]
  35. Wise W. C., Cook J. A., Eller T., Halushka P. V. Ibuprofen improves survival from endotoxic shock in the rat. J Pharmacol Exp Ther. 1980 Oct;215(1):160–164. [PubMed] [Google Scholar]
  36. van Leenen D., van der Poll T., Levi M., ten Cate H., van Deventer S. J., Hack C. E., Aarden L. A., ten Cate J. W. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol. 1993 Aug 15;151(4):2318–2325. [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES